4-Bromo-2,3-dimethylpyridine, 95.0%, 250mg

12-Oxa-3,6,9-triazatetradecanoic acid, 6-(carboxymethyl)-3,9-bis[2-(1,1-dimethylethoxy)-2-oxoethyl]-13,13-dimethyl-11-oxo-, 1-(1,1-dimethylethyl) ester, 98%, 250mg

Methylmalonic acid diethyl ester, 97.0%, 25g

3,4-Bis(2-methoxyethoxy)benzaldehyde, 95.0%, 5g

Methyl 3-cyclopropylprop-2-ynoate, 95%, 250mg

7-Chloro-5-cyclopropyl-[1,2,4]triazolo[1,5-a]pyrimidine, 97%, 10g

4-(3-Acetyl-2-hydroxy-4,6-dimethoxyphenyl)-1-methylpiperidin-3-yl acetate, 98%, 1g

4-Hydroxy-5-methoxy-1-methylquinolin-2(1H)-one, 95%, 100mg

5-Bromo-2-isopropoxypyridine, 97.0%, 5g

2H-Indazole, 2-[(2-chloro-4-fluorophenyl)Methyl]-3-(4-fluorophenyl)-7-(trifluoroMethyl)-, 5mg

3-Bromo-8-chloro-1,5-naphthyridine, 95.0%, 1g

3-Methoxy-N-(piperidine-4-yl)benzamido hydrochloride, 95.0%, 50mg

L-Valine, min 98.5%, USP, for biochemistry, 250 g, plastic packaging.